Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 1
2005 1
2006 2
2007 5
2008 1
2009 2
2010 2
2011 2
2012 3
2013 3
2015 5
2016 8
2017 4
2018 2
2019 9
2020 12
2021 12
2022 11
2023 15
2024 16
2025 16
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Association of Probiotics with Effectiveness of Nivolumab or Pembrolizumab in Patients with Esophageal Cancer Taking Proton Pump Inhibitors: A Multicenter Retrospective Study.
Fujimoto A, Uozumi R, Fujii H, Tamaki S, Eto T, Yamaguchi M, Maehara Y, Iihara H, Hatakeyama T, Higuchi A, Kawazoe H, Ohtani H. Fujimoto A, et al. Among authors: iihara h. J Gastrointest Cancer. 2026 May 25;57(1):125. doi: 10.1007/s12029-026-01499-7. J Gastrointest Cancer. 2026. PMID: 42183961
Prevalence of antibody drug conjugated-induced nausea and vomiting (ADCINV) in patients with cancer.
Chow R, Zhang D, Kannout S, Ma A, Zheng C, Blayne A, Dou A, Talwar S, Fazelzad R, Rugo HS, Ruhlmann CH, Iihara H, Affronti ML, Leigh J, Scotté F, Eng L; MASCC Antiemetic Study Group and the MASCC Emerging Toxicities Study Group. Chow R, et al. Among authors: iihara h. Support Care Cancer. 2026 May 2;34(5):486. doi: 10.1007/s00520-026-10674-2. Support Care Cancer. 2026. PMID: 42068413 Free PMC article.
Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team.
Iimura Y, Higuchi J, Maeda A, Shimomura K, Iihara H, Fujii H, Iwamoto T, Saito Y, Nomura H, Komori K, Tokuda H, Urakawa R, Sumiya T, Yanai R, Kono M, Ihira M, Kurokawa T, Ishii Y, Uchiyama M, Yamada T, Tsuda Y, Tsuchiya Y, Hayashi T, Kuroda S. Iimura Y, et al. Among authors: iihara h. Int J Clin Oncol. 2026 Jun;31(6):957-967. doi: 10.1007/s10147-026-03044-9. Epub 2026 Apr 16. Int J Clin Oncol. 2026. PMID: 41989665 Free PMC article. Review.
Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer.
Takada S, Nasu I, Uozumi R, Kondo M, Nawata S, Iihara H, Okumura Y, Hashishita H, Takemoto M, Okada T, Kitamura Y, Oizumi S, Fukuda S, Kusumoto S, Endo J, Kawazoe H, Nakamura T. Takada S, et al. Among authors: iihara h. Sci Rep. 2026 Apr 3;16(1):16031. doi: 10.1038/s41598-026-46185-7. Sci Rep. 2026. PMID: 41932994 Free PMC article.
Proton-pump inhibitors and palbociclib or abemaciclib in endocrine-sensitive breast cancer treatment.
Takada S, Takahashi K, Uozumi R, Mukohara T, Hayashida T, Iwabe M, Iihara H, Kusuhara-Mamishin K, Tahatsu K, Kitagawa Y, Tsuchiya M, Kitahora M, Umehara K, Nagayama A, Kosaka S, Asano-Niwa Y, Watanabe K, Seki T, Ohnuki K, Futamura M, Kawazoe H, Nakamura T. Takada S, et al. Among authors: iihara h. Sci Rep. 2026 Feb 6;16(1):7551. doi: 10.1038/s41598-026-39093-3. Sci Rep. 2026. PMID: 41651969 Free PMC article.
Effectiveness of polypharmacy measures consisting of a pharmacist check followed by a multidisciplinary team review in patients with poly-pharmacy admitted to a neurology ward.
Yamada S, Nishida S, Hayashi Y, Kunieda K, Yoshikura N, Asai N, Yamada M, Watanabe D, Shimizu S, Fujii H, Iihara H, Niwa T, Kobayashi R, Shimohata T, Suzuki A. Yamada S, et al. Among authors: iihara h. Pharmazie. 2025 Oct 1;80(9):102-107. doi: 10.1692/ph.2025.5555. Pharmazie. 2025. PMID: 41145992 Free article.
125 results